Evidence map›Paper›PMID 31265901›Full record

ArticleThe Journal of steroid biochemistry and molecular biology2019

DLK1/PREF1 marks a novel cell population in the human adrenal cortex.

Irene Hadjidemetriou, Katia Mariniello, Gerard Ruiz-Babot, James Pittaway, Alessandra Mancini, Demetris Mariannis, Celso E Gomez-Sanchez, Laila Parvanta, William M Drake, Teng-Teng Chung and 7 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of steroid biochemistry and molecular biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.7field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 21 citations in OpenAlex.

  1. Article
  2. DLK1: a novel therapeutic target in cancer.Endocrine-related cancer · 2026
    Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 6 institutions in 2 countries.

Irene HadjidemetriouCentre for Endocrinology, William Harvey Research Institute, Bart's and the London, School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Katia MarinielloCentre for Endocrinology, William Harvey Research Institute, Bart's and the London, School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Gerard Ruiz-BabotCentre for Endocrinology, William Harvey Research Institute, Bart's and the London, School of Medicine and Dentistry, Queen Mary University of London, London, UK.
James PittawayCentre for Endocrinology, William Harvey Research Institute, Bart's and the London, School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Alessandra ManciniCentre for Endocrinology, William Harvey Research Institute, Bart's and the London, School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Demetris MariannisCentre for Endocrinology, William Harvey Research Institute, Bart's and the London, School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Celso E Gomez-SanchezG.V. (Sonny) Montgomery VA Medical Center and Department of Medicine, University of Mississippi Medical Centre, Jackson MS, USA.
Laila ParvantaDepartment of Surgery, St Bartholomew's Hospital, West Smithfield, London, EC1A 7BE, UK.
William M DrakeCentre for Endocrinology, William Harvey Research Institute, Bart's and the London, School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Teng-Teng ChungDepartment of Endocrinology, University College Hospital NHS Foundation Trust, NW1 2PG, London, UK.
Tarek Ezzat Abdel-AzizDepartment of Endocrinology, University College Hospital NHS Foundation Trust, NW1 2PG, London, UK.
Aimee DiMarcoDepartment of Endocrine and Thyroid Surgery, Hammersmith Hospital, Imperial College London, London, UK.
Fausto F PalazzoDepartment of Endocrine and Thyroid Surgery, Hammersmith Hospital, Imperial College London, London, UK.
Margaret E WiermanDivision of Endocrinology, Metabolism and Diabetes, University of Colorado School of Medicine, Aurora, CO, USA; Research Service, Rocky Mountain Regional Veterans Affairs Medical Center, Denver, Aurora, CO, USA.
Katja Kiseljak-VassiliadesDivision of Endocrinology, Metabolism and Diabetes, University of Colorado School of Medicine, Aurora, CO, USA; Research Service, Rocky Mountain Regional Veterans Affairs Medical Center, Denver, Aurora, CO, USA.
Peter J KingCentre for Endocrinology, William Harvey Research Institute, Bart's and the London, School of Medicine and Dentistry, Queen Mary University of London, London, UK.
Leonardo GuastiCentre for Endocrinology, William Harvey Research Institute, Bart's and the London, School of Medicine and Dentistry, Queen Mary University of London, London, UK. Electronic address: l.guasti@qmul.ac.uk.
Queen Mary University of London · GBHammersmith Hospital · GBRocky Mountain MS Center · USUniversity College Hospital · GBSt Bartholomew's Hospital · GBUniversity of Mississippi · US

Funding

Tracking and Evaluation CoreU54GM115428 · NIGMS · UNIVERSITY OF MISSISSIPPI MED CTR · PI COMPRETTA, CAROLINE E. · 2016 to 2025
$38.2M
ROLE OF MINERALOCORTICOIDS IN LOW-RENIN HYPERTENSIONR01HL027255 · NHLBI · UNIVERSITY OF SOUTH FLORIDA · PI GOMEZ-SANCHEZ, CELSO ENRIQUE · 1985 to 2017
$3.9M
Identifying and Characterizing Therapeutic Targets in Adrenal CancerK08CA222620 · NCI · UNIVERSITY OF COLORADO DENVER · PI KISELJAKVASSILIADES, KATJA · 2018 to 2022
$1.0M
BLRD VA I01 BX004665Medical Research Council MR/S022155/1NCI NIH HHS K08 CA222620NHLBI NIH HHS R01 HL027255NIGMS NIH HHS U54 GM115428
6 · The paper itself

Abstract

The adrenal cortex governs fundamental metabolic processes though synthesis of glucocorticoid, mineralocorticoids and androgens. Studies in rodents have demonstrated that the cortex undergoes a self-renewal process and that capsular/subcapsular stem/progenitor cell pools differentiate towards functional steroidogenic cells supporting the dynamic centripetal streaming of adrenocortical cells throughout life. We previously demonstrated that the Notch atypical ligand Delta-like homologue 1 (DLK1)/preadipocyte factor 1 (PREF1) is expressed in subcapsular Sf1 and Shh-positive, CYP11B1-negative and CYP11B2-partially positive cortical progenitor cells in rat adrenals, and that secreted DLK1 can modulate GLI1 expression in H295R cells. Here we show that the human adrenal cortex remodels with age to generate clusters of relatively undifferentiated cells expressing DLK1. These clusters (named DLK1-expressing cell clusters or DCCs) increased with age in size and were found to be different entities to aldosterone-producing cell clusters, another well-characterized and age-dependent cluster structure. DLK1 was markedly overexpressed in adrenocortical carcinomas but not in aldosterone-producing adenomas. Thus, this data identifies a novel cell population in the human adrenal cortex and might suggest a yet-to be identified role of DLK1 in the pathogenesis of adrenocortical carcinoma in humans.

Indexed as

Adrenal CortexAldosteroneCalcium-Binding ProteinsCytochrome P-450 Enzyme SystemHumansMembrane ProteinsAldosteroneCalcium-Binding ProteinsCytochrome P-450 Enzyme SystemDLK1 protein, humanMembrane ProteinsAdrenal cortexAdrenocortical carcinomaDLK1RemodelingSteroidogenesis

Identifiers

PMID31265901
PMCPMC6736711
OpenAlexW2955341676

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.